Identification and quantitation of intracellular retinol and retinoic acid binding proteins in cultured cells. 1984

M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell

Although the mechanism whereby vitamin A mediates normal cell differentiation and inhibits tumor cell proliferation is unknown, intracellular receptor-like proteins for retinol and retinoic acid have been implicated in the molecular action of vitamin A. We have assayed these two binding proteins, cellular retinol binding protein (protein R) and cellular retinoic acid binding protein (protein RA), in the cytosolic fraction of various normal and tumor cells via sucrose density gradient centrifugation and saturation analysis. Employing charcoal separation of bound and free tritiated retinoid, the saturation analysis yields an approximate Kd for ligand binding and an estimate of the number of protein R and protein RA molecules per cell. Unique protein R and protein RA macromolecules sedimenting at 2 S with Kd values of 7-42 nM are detected in murine cells (1 degree epidermal, 3T6 fibroblasts and melanoma) and human neuroblastoma cells. Concentrations of the intracellular binding proteins range from 55 000 to 3 000 000 copies per cell. When one cell line (C-127 mouse mammary) is transformed by bovine papilloma virus, protein RA levels increase from undetectable to 193 000 copies per cell. Assessment of growth inhibition by 10(-6) M retinol or retinoic acid in the culture medium reveals that there exists a partial, but not absolute, correlation between the presence of protein R or protein RA and the antiproliferative effect of the particular retinoid in the tested cell lines. We conclude that the 2 S intracellular binding proteins for the retinoids are present in most vitamin A responsive cells, but may not be essential for biologic actions of the vitamin such as growth inhibition in monolayer culture.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004817 Epidermis The external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: (1) basal layer (stratum basale epidermidis); (2) spinous layer (stratum spinosum epidermidis); (3) granular layer (stratum granulosum epidermidis); (4) clear layer (stratum lucidum epidermidis); and (5) horny layer (stratum corneum epidermidis).
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012177 Retinol-Binding Proteins Proteins which bind with RETINOL. The retinol-binding protein found in plasma has an alpha-1 mobility on electrophoresis and a molecular weight of about 21 kDa. The retinol-protein complex (MW Retinoid Binding Protein,Retinol Binding Protein,Retinoid Binding Protein, F-Type,Retinoid Binding Proteins,Retinol Binding Proteins,Binding Protein, Retinoid,Binding Protein, Retinol,Binding Proteins, Retinoid,Binding Proteins, Retinol,Protein, Retinoid Binding,Protein, Retinol Binding,Retinoid Binding Protein, F Type
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid

Related Publications

M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
May 2001, Proteins,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
January 1978, World review of nutrition and dietetics,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
January 1983, Advances in nutritional research,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
June 1977, Nutrition reviews,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
October 1978, Investigative ophthalmology & visual science,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
October 1979, Federation proceedings,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
August 1986, British journal of obstetrics and gynaecology,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
January 1987, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
August 1993, Diabetes,
M R Haussler, and C A Donaldson, and M A Kelly, and D J Mangelsdorf, and G T Bowden, and W J Meinke, and F L Meyskens, and N Sidell
December 1976, Investigative ophthalmology,
Copied contents to your clipboard!